Prof. G.R. Scott Budinger (Northwestern University Feinberg School of Medicine, Chicago, IL, USA) presented current data concerning COVID-19 patients at imminent risk of dying due to ARDS who had received lung transplantations [1–4]. He started off by saying that “patients with COVID-19-associated ARDS who received lung transplants had similar outcomes compared with transplant patients without COVID-19, despite modestly increased early post-op complications.”
In the retrospective study, Prof. Budinger mostly focused on the case series including 102 patients who underwent a lung transplant at Northwestern Memorial Hospital between January 2020 and September 2021, including 30 patients who had COVID-19-associated ARDS [3]. While rates of transplant complications and lengths of intensive care unit stays were both higher in the group with COVID-19, patient survival in both groups was not significantly different. Overall, this data was very similar to that of the other studies [2,4].
Prof. Budinger pointed out that this finding is encouraging for the treatment of patients with COVID-19 who have no other options. Furthermore, the collective data can reassure the community that precious resources such as donor lungs will not necessarily have poorer outcomes in candidates with COVID-19.
- Budinger GS, et al.Lung Transplantation for COVID-19-Associated ARDS. Session A2, ATS International Conference 2022, San Francisco, CA, USA, 13–18 May.
- Bharat A, et al. Lancet Respir Med. 2021 May;9(5):487–497.
- Kurihara C, et al. JAMA. 2022 Feb 15;327(7):652–661.
- Roach A, et al. N Engl J Med. 2022 Mar 24;386(12):1187–1188.
Copyright ©2022 Medicom Medical Publishers
Posted on
Previous Article
« JAK inhibition offers promising treatment prospects for uncommon dermatoses Next Article
SPRINTER still in the running? »
« JAK inhibition offers promising treatment prospects for uncommon dermatoses Next Article
SPRINTER still in the running? »
Table of Contents: ATS 2022
Featured articles
No screening evidence for COPD
Online First
Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?
Novel P2X3 antagonist can SOOTHE chronic cough
PAGANINI phase 2b data promising for eliapixant
POISE-3: Tranexamic acid for non-cardiac surgery
Colistimethate sodium PROMISing for non-cystic fibrosis bronchiectasis
Type 2 asthma managed by dupilumab, despite atopic comorbidities
NAVIGATOR steers asthma patients to tezepelumab
No screening evidence for COPD
High-intensity interval training slashes daily corticosteroids in asthma
Obstructive sleep apnoea in most kids with PH
Novel PDE4B inhibitor offers breakthrough for IPF
MANDALA patterns success for albuterol-budesonide in asthma
Lung transplantation after COVID-19-associated ARDS
Hydrocortisone does not help pre-term infants
CPAP supports pulmonary oxygenation in morbidly obese patients
Related Articles
April 22, 2021
Targeted interventions improve infant bronchiolitis care
November 7, 2018
Endoscopic treatment of asthma
© 2023 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy